Wissenschaftliche Arbeiten

Doç. Dr. Derya Kocakaya

140 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Autoantibody Positivity in Patients with Hypersensitivity Pneumonitis: A Subgroup Analysis of the TURK-HP Study Cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1967 Quelle: OpenAlex

  2. Antifibrotic Use in Hypersensitivity Pneumonitis: Real-World Data from a Subgroup Analysis of the TURK-HP Cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6288 Quelle: OpenAlex

  3. Regional Differences in Exposure Histories Among Patients Diagnosed with Hypersensitivity Pneumonitis: A Subgroup Analysis of TURK-HP Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6287 Quelle: OpenAlex

  4. Regional Variability in Diagnostic Approaches to Hypersensitivity Pneumonitis: Results From A National Multicenter Real-World Cohort (TURK-HP)

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6286 Quelle: OpenAlex

  5. Clinical, radiological and regional characteristics of hypersensitivity pneumonitis:The Turkish national cohort (TURK-HP study)

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6292 Quelle: OpenAlex

  6. Pleuroparenchymal fibroelastosis in Turkey: a multicentre real-world experience

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3086 Quelle: OpenAlex

  7. Rare Interstitial Lung Diseases in the Elderly: A Different Spectrum?

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3089 Quelle: OpenAlex

  8. Factors Associated with Disease Progression in Pulmonary Langerhans Cell Histiocytosis: Data from the TRILD Registry

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5275 Quelle: OpenAlex

  9. Diffuse Cystic Lung Diseases in Türkiye: TRILD National Multicenter Cohort Analysis

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5277 Quelle: OpenAlex

  10. Clinical heterogeneity and progression risk in pulmonary alveolar microlithiasis: a multicenter real-world cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa891 Quelle: OpenAlex

  11. Real-World Characteristics of Rare Interstitial Lung Diseases: Results from the TRILD Registry

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5284 Quelle: OpenAlex

  12. Lymphangioleiomyomatosis in Türkiye: Real-World Data from the TRILD Registry

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5268 Quelle: OpenAlex

  13. Real-world pulmonary phenotype and diagnostic pathways in Birt–Hogg–Dubé syndrome: a nationwide multicenter cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5276 Quelle: OpenAlex

  14. The Role of Genetic Testing in Rare Interstitial Lung Diseases: TRILD Registry Results

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3087 Quelle: OpenAlex

  15. Frequency of liver involvement and its association with genotype in patients with cystic fibrosis

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3954 Quelle: OpenAlex

  16. Underestimated value of Hounsfield unit in differentiating benign and malignant lymph nodes via EBUS-TBNA

    BMC Pulmonary Medicine, 2026

    DOI 10.1186/s12890-026-04557-9 PMID 42968115 Frei zugänglicher VolltextQuelle: ORCID

  17. Patient-level critical care trajectories in adults with cystic fibrosis in Türkiye: A seven-year single-center case series

    Respiratory Medicine Case Reports, 2026

    DOI 10.1016/j.rmcr.2026.102504 PMID 42866542 Frei zugänglicher VolltextQuelle: ORCID

  18. International Delphi consensus recommendations for the follow-up of children born to people with CF and exposed to CFTR modulators in utero or through breastfeeding; endorsed by the European Cystic Fibrosis Society

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/j.jcf.2026.04.006 PMID 42049593 Frei zugänglicher VolltextQuelle: OpenAlex

  19. Frequency of liver involvement and its association with genotype in patients with cystic fibrosis

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/s1569-1993(26)00630-2 Quelle: OpenAlex

  20. E-Cigarette or Vaping Product Use–Associated Lung Injury (EVALI) mimicking chronic interstitial lung disease in a young adult: a case report

    Egyptian Journal of Bronchology, 2026

    DOI 10.1186/s43168-026-00665-6 Frei zugänglicher VolltextQuelle: OpenAlex

  21. Additional file 1 of E-Cigarette or Vaping Product Use–Associated Lung Injury (EVALI) mimicking chronic interstitial lung disease in a young adult: a case report

    Figshare, 2026

    DOI 10.6084/m9.figshare.33421676 Frei zugänglicher VolltextQuelle: OpenAlex

  22. Poster: 593Adult cystic fibrosis in the intensive care unit: A single-center study of patterns of care, utilization, and clinical outcomes

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/j.jcf.2026.07.633 Quelle: OpenAlex

  23. Clinical course and radiological outcomes of pulmonary artery thrombosis in Behcet's Diseases: A comparative study with non-Behcet's Disease pulmonary thrombosis

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa939 Quelle: OpenAlex

  24. E-cigarette–associated lung injury mimicking interstitial lung disease: a case report

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3804 Quelle: OpenAlex

  25. Healthy Homes, Healthy Lungs: The Role of Home Insulation in Environmental Impact on People With Cystic Fibrosis

    Pediatric Pulmonology, 2025

    DOI 10.1002/ppul.71253 PMID 40873110 1 Zitation (OpenAlex) Quelle: OpenAlex

  26. Lactate-Albumin Ratio: A Novel Predictor of Noninvasive Mechanical Ventilation Failure in Acute Hypercapnic Respiratory Failure

    Cureus, 2025

    DOI 10.7759/cureus.83314 PMID 40452710 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  27. P437 The effect of group psychotherapy on anxiety, depression, and quality of life in cystic fibrosis: a pilot study

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1321 Quelle: OpenAlex

  28. ABS0728 THE CLINICAL CHARACTERISTICS AND 2-YEAR FOLLOW-UP OF TAKAYASU ARTERITIS PATIENTS WITH PULMONARY ARTERY INVOLVEMENT

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.2037 Frei zugänglicher VolltextQuelle: OpenAlex

  29. The relationship between preoperative clinical, respiratory, and hemodynamic parameters and the surgical anatomical classification of thrombi in patients with chronic thromboembolic pulmonary hypertension

    BMC Pulmonary Medicine, 2025

    DOI 10.1186/s12890-025-03998-y PMID 41272601 Frei zugänglicher VolltextQuelle: OpenAlex

  30. The frequency of thyroid disease and treatment in chronic thromboembolic pulmonary hypertension and their effect on outcomes

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa912 Quelle: OpenAlex

  31. Evaluation of Sexual Quality of Life and Affecting Clinical and Psychosocial Factors in Women and Men with Pulmonary Hypertension

    Sexuality and Disability, 2025

    DOI 10.1007/s11195-025-09928-4 Quelle: OpenAlex

  32. Description of an activity-based enzyme biosensor for lung cancer detection

    Communications Medicine, 2024

    DOI 10.1038/s43856-024-00461-7 PMID 38443590 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  33. Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission

    Turkish Journal of Internal Medicine, 2024

    DOI 10.46310/tjim.1502238 Frei zugänglicher VolltextQuelle: OpenAlex

  34. Childhood interstitial lung disease survivors in adulthood: a European collaborative study

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.00680-2024 PMID 39638417 11 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  35. The impact of indoor environment factors on respiratory conditions among both children and adults in Turkey

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa469 2 Zitationen (OpenAlex) Quelle: OpenAlex

  36. Children’s ILDs survivors in adulthood: a European Study

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.oa1066 Quelle: OpenAlex

  37. Home insulation and mold exposure: assessing their influence on lung function in people with cystic fibrosis

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.oa3773 Quelle: OpenAlex

  38. Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic

    Turkish Journal of Pharmaceutical Sciences, 2024

    DOI 10.4274/tjps.galenos.2023.47105 PMID 38742835 Frei zugänglicher VolltextQuelle: ORCID

  39. The Association of Depression with Obstructive Sleep Apnea in Patients with Cystic and Non-Cystic Fibrosis Bronchiectasis

    Life, 2024

    DOI 10.3390/life14081026 PMID 39202768 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  40. Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?

    Respiratory Medicine, 2024

    DOI 10.1016/j.rmed.2023.107481 PMID 38035945 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  41. Anticoagulant Treatment May Decrease the Relapse Rate of Pulmonary Arterial Involvement in Behçet’s Disease

    JCR Journal of Clinical Rheumatology, 2024

    DOI 10.1097/rhu.0000000000002137 PMID 39413301 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  42. Pulmonary Endarterectomy: Risk Factors for Early and Late Mortality

    The Thoracic and Cardiovascular Surgeon, 2024

    DOI 10.1055/a-2409-5944 PMID 39231495 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  43. Stem cell treatment reduces T cell apoptosis in COPD patients with chronic bronchitis but not with emphysema

    Tissue and Cell, 2024

    DOI 10.1016/j.tice.2024.102452 PMID 38986345 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  44. Impact of Anxiety, Depression, and Coping Strategies on Health-Related Quality of Life in Patients with Cystic Fibrosis

    Thoracic research and practice, 2024

    DOI 10.5152/thoracrespract.2024.23112 PMID 38705998 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  45. POS0276 ANTICOAGULANT TREATMENT IN ADDITION TO IMMUNOSUPPRESSIVES DECREASES THE RELAPSE RATE IN PULMONARY ARTERIAL INVOLVEMENT OF BEHÇET’S DISEASE

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.4605 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  46. Stem cell treatment reduces T cell apoptosis in COPD patients with chronic bronchitis but not with emphysema

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa4405 Quelle: OpenAlex

  47. CAN LACTATE ALBUMIN RATIO BE A MARKER TO PREDICT THE OUTCOMES OF PATIENTS WITH COPD EXACERBATION?

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa3887 Quelle: OpenAlex

  48. The effect of age on mortality after pulmonary endarterectomy

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa761 Quelle: OpenAlex

  49. Associates of Neutrophil/lymphocyte Ratio in Patients with COVID 19 Infection: A Single Center Experience

    Research Square, 2024

    DOI 10.21203/rs.3.rs-5338049/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  50. A Rare Geriatric Case: Omalizumab As a Rescue Therapy For Asthma-Chronic Obstructive Pulmonary Disease Overlap

    European Journal of Geriatrics and Gerontology, 2024

    DOI 10.4274/ejgg.galenos.2024.2024-10-3 Frei zugänglicher VolltextQuelle: OpenAlex